These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 15349008

  • 1. Valproic acid-induced hyperammonemia: a case report.
    McCall M, Bourgeois JA.
    J Clin Psychopharmacol; 2004 Oct; 24(5):521-6. PubMed ID: 15349008
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Metabolic encephalopathy can be a potentially life-threatening complication from valproic acid].
    Meinardi MC, van den Berg GB, Groenhuijzen A, Driessen JT, Maas HA, Wolfhagen FH.
    Ned Tijdschr Geneeskd; 2008 Feb 02; 152(5):278-82. PubMed ID: 18333544
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy].
    Yamada H, Shishido T, Mukai T, Araki M, Naka H, Tokinobu H.
    Rinsho Shinkeigaku; 2019 May 28; 59(5):258-263. PubMed ID: 31061301
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy.
    Tseng YL, Huang CR, Lin CH, Lu YT, Lu CH, Chen NC, Chang CC, Chang WN, Chuang YC.
    Medicine (Baltimore); 2014 Sep 28; 93(11):e66. PubMed ID: 25192484
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Valproate-induced hyperammonemic encephalopathy.
    Murphy JV.
    Epilepsia; 2003 Feb 28; 44(2):268; author reply 268. PubMed ID: 12558587
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.
    Velioğlu SK, Gazioğlu S.
    Acta Neurol Scand; 2007 Aug 28; 116(2):128-32. PubMed ID: 17661800
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A case of hyperammonaemic encephalopathy due to valproic acid.
    Prins MC, van Meijel JJ.
    Neth J Med; 2011 Sep 28; 69(9):389-91. PubMed ID: 21978982
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hyperammonemia following intravenous valproate loading.
    DeWolfe JL, Knowlton RC, Beasley MT, Cofield S, Faught E, Limdi NA.
    Epilepsy Res; 2009 Jul 28; 85(1):65-71. PubMed ID: 19299111
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy.
    Barrueto F, Hack JB.
    Acad Emerg Med; 2001 Oct 28; 8(10):999-1001. PubMed ID: 11581089
    [Abstract] [Full Text] [Related]

  • 19. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
    Rigamonti A, Lauria G, Grimod G, Bianchi G, Salmaggi A.
    J Clin Neurosci; 2014 Apr 28; 21(4):690-1. PubMed ID: 24119342
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.